Schedule 13G ownership disclosure

CORREVIO PHARMA CORP

Security class unavailable · CUSIP: 22026V105

Event date: 2018-12-31

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
424,101
Percent of class
1.2000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-19-000105
Form type
SC 13G/A
Filer
Correvio Pharma Corp.
CIK
CIK 1036141
Filed
Feb 13, 2019
Reporting period
Dec 31, 2018
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub